Michael A. Erb

4.9k total citations · 2 hit papers
49 papers, 2.9k citations indexed

About

Michael A. Erb is a scholar working on Molecular Biology, Epidemiology and Surgery. According to data from OpenAlex, Michael A. Erb has authored 49 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 7 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Michael A. Erb's work include Protein Degradation and Inhibitors (15 papers), Ubiquitin and proteasome pathways (14 papers) and Histone Deacetylase Inhibitors Research (7 papers). Michael A. Erb is often cited by papers focused on Protein Degradation and Inhibitors (15 papers), Ubiquitin and proteasome pathways (14 papers) and Histone Deacetylase Inhibitors Research (7 papers). Michael A. Erb collaborates with scholars based in United States, Austria and Switzerland. Michael A. Erb's co-authors include James E. Bradner, Georg Winter, Nathanael S. Gray, Joshiawa Paulk, Thomas G. Scott, Dennis L. Buckley, Matthew A. Lawlor, Behnam Nabet, Jun Qi and Justin M. Roberts and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Michael A. Erb

48 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The dTAG system for immediate and target-specific protein degradation

2018 652 citations Behnam Nabet, Justin M. Roberts et al. Nature Chemical Biology profile →
Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation

2017 402 citations Baishan Jiang, Michael A. Erb et al. Nature Chemical Biology profile →

Peers

Countries citing papers authored by Michael A. Erb

Since Specialization

Citations

This map shows the geographic impact of Michael A. Erb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Erb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Erb more than expected).

Fields of papers citing papers by Michael A. Erb

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Erb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Erb. The network helps show where Michael A. Erb may publish in the future.

Co-authorship network of co-authors of Michael A. Erb

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Erb. A scholar is included among the top collaborators of Michael A. Erb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Erb. Michael A. Erb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	SuFEx-based chemical diversification for the systematic discovery of CRBN molecular glues 2024 ·Bioorganic & Medicinal Chemistry ·(unknown), Natalia Milosevich, (unknown), (unknown), K. Barry Sharpless, Seiya Kitamura, Michael A. Erb	13
2	Small-molecule tools for YEATS domain proteins 2023 ·Current Opinion in Chemical Biology ·Michael A. Erb	4
3	Collateral lethality between HDAC1 and HDAC2 exploits cancer-specific NuRD complex vulnerabilities 2023 ·Nature Structural & Molecular Biology ·Yuxiang Zhang, David Remillard, (unknown), (unknown), Joshua N. Asiaban, (unknown), (unknown), (unknown), (unknown), Stephanie Nance, Adam D. Durbin, Christopher J. Ott, Michalina Janiszewska, Benjamin F. Cravatt, Michael A. Erb	15
4	A short ORF-encoded transcriptional regulator 2021 ·Proceedings of the National Academy of Sciences ·Minseob Koh, Insha Ahmad, Yeonjin Ko, Yuxiang Zhang, Thomas F. Martínez, Jolene K. Diedrich, Qian Chu, James J. Moresco, Michael A. Erb, Alan Saghatelian, Peter G. Schultz, Michael J. Bollong	38
5	Chemical Inhibition of ENL/AF9 YEATS Domains in Acute Leukemia 2021 ·ACS Central Science ·(unknown), (unknown), Seiya Kitamura, Natalia Milosevich, Joshua N. Asiaban, Xiaoyu Zhang, Qinheng Zheng, Emily Chen, (unknown), (unknown), Eric Hampton, Arnab K. Chatterjee, Travis S. Young, Mitchell Hull, K. Barry Sharpless, Benjamin F. Cravatt, Dennis W. Wolan, Michael A. Erb	63
6	Reproducibility of GMP-compliant production of therapeutic stressed peripheral blood mononuclear cell-derived secretomes, a novel class of biological medicinal products 2020 ·Stem Cell Research & Therapy ·Maria Laggner, Alfred Gugerell, Christiane Bachmann, (unknown), Vera Vorstandlechner, (unknown), (unknown), Anja Peterbauer, Sibylle Madlener, Svitlana Demyanets, (unknown), Tobias Ostler, Michael A. Erb, Michael Mildner, Hendrik Jan Ankersmit	38
7	Tissue-regenerative potential of the secretome of γ-irradiated peripheral blood mononuclear cells is mediated via TNFRSF1B-induced necroptosis 2019 ·Cell Death and Disease ·Elisabeth Simader, Lucian Beer, Maria Laggner, Vera Vorstandlechner, Alfred Gugerell, Michael A. Erb, (unknown), Dragan Copic, Doris Moser, Andreas Spittler, Erwin Tschachler, Hendrik Jan Ankersmit, Michael Mildner	26
8	Toxicological testing of allogeneic secretome derived from peripheral mononuclear cells (APOSEC): a novel cell-free therapeutic agent in skin disease 2019 ·Scientific Reports ·(unknown), Alfred Gugerell, Monika Chabicovsky, (unknown), Maria Laggner, Michael A. Erb, Tobias Ostler, Anja Peterbauer, (unknown), Svitlana Demyanets, J Leuschner, Bernhard Moser, Michael Mildner, Hendrik Jan Ankersmit	16
9	Different pro-angiogenic potential of γ-irradiated PBMC-derived secretome and its subfractions 2018 ·Scientific Reports ·(unknown), Denise Traxler, Elisabeth Simader, Lucian Beer, Marie‐Sophie Narzt, Флориан Грубер, Sibylle Madlener, Maria Laggner, Michael A. Erb, Vera Vorstandlechner, Alfred Gugerell, Christine Radtke, Massimiliano Gnecchi, Anja Peterbauer, Maria Gschwandtner, Erwin Tschachler, Claudia Keibl, Paul Slezak, Hendrik Jan Ankersmit, Michael Mildner	35
10	Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma 2018 ·Nature Genetics ·Rhamy Zeid, Matthew A. Lawlor, Evon Poon, Jaime M. Reyes, Mariateresa Fulciniti, Michael Lopez, Thomas G. Scott, Behnam Nabet, Michael A. Erb, Georg E. Winter, (unknown), (unknown), Kristen L. Karlin, Rachel Hirsch, Nikhil Munshi, Thomas F. Westbrook, Louis Chesler, Charles Y. Lin, James E. Bradner	129
11	Endocarditis: An Ever Increasing Problem in Cardiac Surgery 2018 ·The Thoracic and Cardiovascular Surgeon ·(unknown), (unknown), (unknown), (unknown), T.H. Claus, Michael A. Erb, Johannes M. Albes	3
12	Functional TRIM24 degrader via conjugation of ineffectual bromodomain and VHL ligands 2018 ·Nature Chemical Biology ·(unknown), Dennis L. Buckley, Matthew A. Lawlor, Jaime M. Reyes, Joshiawa Paulk, Christopher J. Ott, Georg Winter, Michael A. Erb, Thomas G. Scott, Mousheng Xu, Hyuk‐Soo Seo, Sirano Dhe‐Paganon, Nicholas Kwiatkowski, Jennifer A. Perry, Jun Qi, Nathanael S. Gray, James E. Bradner	167
13	Transcription control by the ENL YEATS domain in acute leukaemia 2017 ·RePEc: Research Papers in Economics ·Michael A. Erb, Thomas G. Scott, Bin E. Li, Huafeng Xie, Joshiawa Paulk, Hyuk‐Soo Seo, Amanda Souza, Justin M. Roberts, Shiva Dastjerdi, Dennis L. Buckley, Neville E. Sanjana, Ophir Shalem, Behnam Nabet, Rhamy Zeid, (unknown), Sirano Dhe‐Paganon, Feng Zhang, Stuart H. Orkin, Georg Winter, James E. Bradner	1
14	Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation 2017 ·DSpace@MIT (Massachusetts Institute of Technology) ·(unknown), Baishan Jiang, Michael A. Erb, Yanke Liang, Zainab M. Doctor, Zinan Zhang, (unknown), Nicholas Kwiatkowski, Myriam Boukhali, Jennifer L. Green, Wilhelm Haas, Tyzoon Nomanbhoy, Eric S. Fischer, James E. Bradner, Georg Winter, Nathanael S. Gray, Richard A. Young	1
15	ENL links histone acetylation to oncogenic gene expression in acute myeloid leukaemia 2017 ·Nature ·Liling Wan, Hong Wen, Yuanyuan Li, Jie Lyu, Yuanxin Xi, Takayuki Hoshii, (unknown), Xiaolu Wang, Yong‐Hwee Eddie Loh, Michael A. Erb, Amanda L. Souza, James E. Bradner, Li Shen, Wei Li, Haitao Li, C. David Allis, Scott A. Armstrong, Xiaobing Shi	187
16	Transcription control by the ENL YEATS domain in acute leukaemia 2017 ·Nature ·Michael A. Erb, Thomas G. Scott, Bin E. Li, Huafeng Xie, Joshiawa Paulk, Hyuk‐Soo Seo, Amanda Souza, Justin M. Roberts, Shiva Dastjerdi, Dennis L. Buckley, Neville E. Sanjana, Ophir Shalem, Behnam Nabet, Rhamy Zeid, (unknown), Sirano Dhe‐Paganon, Feng Zhang, Stuart H. Orkin, Georg Winter, James E. Bradner	204
17	Transcription control by the ENL YEATS domain in acute leukemia 2016 ·European Journal of Cancer ·Michael A. Erb, Georg Winter, Shiva Dastjerdi, Thomas G. Scott, Neville E. Sanjana, Ophir Shalem, Dennis L. Buckley, (unknown), James E. Bradner	0
18	Idebenone Protects against Retinal Damage and Loss of Vision in a Mouse Model of Leber’s Hereditary Optic Neuropathy 2012 ·PLoS ONE ·Fabrice D. Heitz, Michael A. Erb, (unknown), (unknown), Vincent Pernet, Nuri Gueven	92
19	NQO1-Dependent Redox Cycling of Idebenone: Effects on Cellular Redox Potential and Energy Levels 2011 ·PLoS ONE ·(unknown), Michael A. Erb, Anja C. Gemperli, (unknown), Isabelle Fruh, (unknown), Robert Dallmann, Nuri Gueven	152
20	Long-term blinded placebo-controlled study of SNT-MC17/idebenone in the dystrophin deficient mdx mouse: cardiac protection and improved exercise performance 2008 ·European Heart Journal ·Gunnar Buyse, Gerry Van der Mieren, Michael A. Erb, Jan D’hooge, Paul Herijgers, Eric Verbeken, Alejandro Jara, An Van den Bergh, Luc Mertens, I. Courdier-Fruh, Patrizia Barzaghi, Thomas Meier	82

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact